Detection of Helicobacter Pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction

Jundishapur Journal of Microbiology

Volumn 8, Issue 1, 2015, Pages

  Fekri, Mitra Samareh ^a   Bajgani, Seyed Mehdi Hashemi ^b   Rasti, Atefe ^a   Yazdani, Rostam ^b   Mollaie, Hamid Reza ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic obstructive pulmonary disease; Helicobacter Pylori; Real Time PCR; Serology; Urease

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BRONCHOSCOPY; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CULTURE MEDIUM; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; DNA EXTRACTION; DYSPHASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGASTRIC PAIN; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOARSENESS; HUMAN; HUMAN TISSUE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PASSIVE SMOKING; PHYSICAL EXAMINATION; PREVALENCE; PROGNOSIS; RAPID UREASE TEST; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; SPIROMETRY; TRANSBRONCHIAL BIOPSY;

HELICOBACTER PYLORI;

EID: 84918784518     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.14551     Document Type: Article

References (44)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-50.
2. Committee GE. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.; 2009.
3. Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G. Woodsmoke exposure and risk for obstructive airways disease among women. Chest. 1996;109(1):115-9.
4. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS, Gold Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46(8):798-825.
5. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161-81.
6. Mitchell H, Megraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter. 2002;7 Suppl 1:8-16.
7. Blaser MJ. Helicobacter pylori and other gastric Helicobacter species. In: Mandell GL, Dolin JR, Bennett R editors. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2010. pp. 2803-13.
8. Cohen H. Peptic Ulcer and Helicobacter Pylori. GastroenterolClin North Am. 2000;29(4):775-89.
9. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330(18):1267-71.
10. Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H. pylori infection with gastric carcinoma: a Meta analysis. World J Gastroenterol. 2001;7(6):801-4.
11. Sherman PM, Lin FY. Extradigestive manifestation of Helicobacter pylori infection in children and adolescents. Can J Gastroenterol. 2005;19(7):421-4.
12. De Koster E, De Bruyne I, Langlet P, Deltenre M. Evidence based medicine and extradigestive manifestations of Helicobacter pylori. Acta Gastroenterol Belg. 2000;63(4):388-92.
13. Gencer M, Ceylan E, Yildiz Zeyrek F, Aksoy N. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests. Respiration. 2007;74(2):170-5.
14. Roussos A, Philippou N, Mantzaris GJ, Gourgoulianis KI. Respiratory diseases and Helicobacter pylori infection: is there a link? Respiration. 2006;73(5):708-14.
15. Malfertheiner MV, Kandulski A, Schreiber J, Malfertheiner P. Helicobacter pylori infection and the respiratory system: a systematic review of the literature. Digestion. 2011;84(3):212-20.
16. Nelson S, Summer WR, Mason CM. The role of the inflammatory response in chronic bronchitis: therapeutic implications. Semin Respir Infect. 2000;15(1):24-31.
17. Silva JR, Jones JA, Cole PJ, Poulter LW. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax. 1989;44(8):668-73.
18. Kellow JE, Tao Z, Piper DW. Ventilatory function in chronic peptic ulcer. A controlled study of ventilatory function in patients with gastric and duodenal ulcer. Gastroenterology. 1986;91(3):590-5.
19. Lundegardh G, Helmick C, Zack M, Adami HO. Mortality among patients with partial gastrectomy for benign ulcer disease. Dig Dis Sci. 1994;39(2):340-6.
20. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997;156(5):1436-9.
21. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530-4.
22. Kountouras J, Boura P, Lygidakis NJ. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Hepatogastroenterology. 2000;47(35):1301-4.
23. Mitz HS, Farber SS. Demonstration of Helicobacter pylori in tracheal secretions. J Am Osteopath Assoc. 1993;93(1):87-91.
24. Mehmet N, Refik M, Harputluoglu M, Ersoy Y, Aydin NE, Yildirim B. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori. New Microbiol. 2004;27(2):139-48.
25. Romero Adriàn T, Leal Montiel J. Helicobacter pylori Infection: Regulatory T Cells and Their Participation in the Immune Response. Jundishapur J Microbiol. 2013;6(4):5183.
26. Cote CG, Pinto-Plata VM, Marin JM, Nekach H, Dordelly LJ, Celli BR. The modified BODE index: validation with mortality in COPD. Eur Respir J. 2008;32(5):1269-74.
27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-12.
28. Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30(10):1030-8.
29. He Q, Wang JP, Osato M, Lachman LB. Real-time quantitative PCR for detection of Helicobacter pylori. J Clin Microbiol. 2002;40(10):3720-8.
30. Kobayashi D, Eishi Y, Ohkusa T, Suzuki T, Minami J, Ishige., et al. Gastric mucosal density of Helicobacter pylori estimated by real-time PCR compared with results of urea breath test and histological grading. J Med Microbiol. 2002;51(4):305-11.
31. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004;97(6):1166-77.
32. Arora OP, Kapoor CP, Sobti P. Study of gastroduodenal abnormalities in chronic bronchitis and emphysema. Am J Gastroenterol. 1968;50(4):289-96.
33. Caselli M, Zaffoni E, Ruina M, Sartori S, Trevisani L, Ciaccia A, et al. Helicobacter pylori and chronic bronchitis. Scand J Gastroenterol. 1999;34(8):828-30.
34. Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevie O. Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health. 2000;28(1):32-40.
35. Roussos A, Tsimpoukas F, Anastasakou E, Alepopoulou D, Paizis I, Philippou N. Helicobacter pylori seroprevalence in patients with chronic bronchitis. J Gastroenterol. 2002;37(5):332-5.
36. Kanbay M, Gur G, Akcay S, Yilmaz U. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med. 2005;99(10):1213-6.
37. Hashemi SH, Nadi E, Hajilooi M, Seif-Rabiei MA, Roustaei U. Relationship between Helicobacter pylori infection and chronic obstructive pulmonary disease. Acta Med Iran. 2011;49(11):721-4.
38. Fullerton D, Britton JR, Lewis SA, Pavord ID, McKeever TM, Fogarty AW. Helicobacter pylori and lung function, asthma, atopy and allergic disease--a population-based cross-sectional study in adults. Int J Epidemiol. 2009;38(2):419-26.
39. Minov J, Karadzinska Bislimovska J, Vasilevska K, Risteska Kuc S, Stoleski S, Mijakoski D. Helicobacter Pyloriinfection in never-smoking male patients with chronic obstructive pulmonary disease and its relation to lung function. Am J Immunol. 2012;8(4):146-53.
40. Siva R, Birring SS, Berry M, Rowbottom A, Pavord ID. Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology. 2013;18(4):728-31.
41. Shams-Hosseini NO, Mousavi SA, Kadivar M, Ahmadipour E, Yazdani R, Moradians V. Helicobacter pylori in patients suffering from pulmonary disease. Tanaffos. 2011;10(1):31-6.
42. Ilvan A, Ozturkeri H, Capraz F, Cermik H, Kunter E. Investigation of Helicobacter pylori in bronchoscopic lung specimens of young male patients with bronchiectasis but without gastrointestinal symptoms. Clin Microbiol Infect. 2004;10(3):257-60.
43. Gulhan M, Ozyilmaz E, Tarhan G, Demirag F, Capan N, Erturk A, et al. Helicobacter pylori in bronchiectasis: a polymerase chain reaction assay in bronchoalveolar lavage fluid and bronchiectatic lung tissue. Arch Med Res. 2007;38(3):317-21.
44. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004;57(1):37-42.